Scholar Rock Holding Corporation (SRRK)
NASDAQ: SRRK · Real-Time Price · USD
45.29
-0.86 (-1.86%)
At close: Mar 6, 2026, 4:00 PM EST
46.19
+0.90 (1.99%)
After-hours: Mar 6, 2026, 5:52 PM EST
Scholar Rock Holding Market Cap
Scholar Rock Holding has a market cap or net worth of $5.2 billion as of March 6, 2026. Its market cap has increased by 46.22% in one year.
Market Cap
5.20B
Enterprise Value
5.01B
1-Year Change
46.22%
Ranking
Category
Stock Price
$45.29
Market Cap Chart
Since May 24, 2018, Scholar Rock Holding's market cap has increased from $378.83M to $5.20B, an increase of 1,273.46%. That is a compound annual growth rate of 40.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 5.30B | 17.99% |
| Dec 31, 2025 | 4.49B | 11.06% |
| Dec 31, 2024 | 4.05B | 198.32% |
| Dec 29, 2023 | 1.36B | 190.08% |
| Dec 30, 2022 | 467.55M | -46.39% |
| Dec 31, 2021 | 872.09M | -46.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 24, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rhythm Pharmaceuticals | 6.12B |
| Protagonist Therapeutics | 6.03B |
| Cogent Biosciences | 5.96B |
| CRISPR Therapeutics AG | 5.77B |
| Immunovant | 5.53B |
| Mirum Pharmaceuticals | 5.53B |
| Caris Life Sciences | 5.49B |
| PTC Therapeutics | 5.41B |